BMY vs VECO · P/E 17, rev $24.46B vs P/E 199, rev $351.8M
Bristol-Myers Squibb Company (BMY) versus Veeco Instruments Inc (VECO) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Veeco Instruments Inc (VECO) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported VECO revenue for 2026-06-30 was $351.8M. Net income was $11.5M. VECO currently screens at market cap $4.63B and trailing P/E 199.4.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. VECO currently screens at market cap $4.63B and trailing P/E 199.4.
Not investment advice. Open the BMY and VECO stock pages for the full models.
Not investment advice.